Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects Reuters Novo Nordisk’s amylin obesity drug keeps performing like…
Read More »Reuters
The Wegovy effect: A new drug reshapes the lives of teens with obesity Reuters Challenges in Clinical Trial Site Selection and…
Read More »By Liz Lee BEIJING (Reuters) – China’s new yuan loans more than tripled in May compared with a month ago,…
Read More »Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says Reuters GLP-1 drugs may be linked to elevated…
Read More »Featured Podcasts Techmeme Ride Home: Big Meta/Anduril Deal Is A Big Deal The day’s tech news, every day at 5pm…
Read More »Featured Podcasts Techmeme Ride Home: Tim Apple’s Very Bad Week The day’s tech news, every day at 5pm ET. Fifteen…
Read More »Featured Podcasts Lenny’s Podcast: Microsoft CPO: If you aren’t prototyping with AI you’re doing it wrong | Aparna Chennapragada Interviews…
Read More »Featured Podcasts Channels with Peter Kafka: How Apple trapped itself in China Media and tech aren’t just intersecting – they’re…
Read More »US Health secretary Kennedy revives misleading claims of ‘fetal debris’ in measles shots Reuters RFK Jr and health agency falsely claim…
Read More »Featured Podcasts Lenny’s Podcast: Everyone’s an engineer now: Inside v0’s mission to create a hundred million builders | Guillermo Rauch…
Read More »